SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-013250
Filing Date
2024-04-25
Accepted
2024-04-25 16:35:56
Documents
16
Period of Report
2024-04-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20240424_8k.htm   iXBRL 8-K 48064
2 EXHIBIT 3.1 ex_659781.htm EX-3.1 17037
3 EXHIBIT 10.1 ex_659782.htm EX-10.1 41018
  Complete submission text file 0001437749-24-013250.txt   262071

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pbla-20240423.xsd EX-101.SCH 3410
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20240423_def.xml EX-101.DEF 11805
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20240423_lab.xml EX-101.LAB 15849
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20240423_pre.xml EX-101.PRE 12020
19 EXTRACTED XBRL INSTANCE DOCUMENT pbla20240424_8k_htm.xml XML 2932
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 24876985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)